BibTex RIS Cite

Current Approaches in the Treatment of Prostatitis

Year 2013, Volume: 22 Issue: 1, 130 - 141, 01.03.2013

Abstract

Prostatitis is an infection or inflammation of the prostate gland that presents as several syndromes with varying clinical features. This painful condition mostly affects young and middle-aged men and diminishes their quality of life. With the recent introduction of a new classification for this disease, more effective approach for the evaluation and management of the patients with chronic pelvic pain syndrome has emerged. Nonetheless, no definitely effective treatment regime has yet been described in the literature.

References

  • Benoit G, Gillpt C, Jardın A. Reflection etpropositionsur la nomenclature de la prostate. Surg Radiol Anat. 1992; 15:325-32.
  • Pfau A. Prostatistis: a continuing enigma. UrolClin North Am. 1986;13:695-715.
  • Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and uretritis. Invest Urol. 1968; 5:492-518.
  • Nickel JC, Downey J, Hunter D, Clark J. Prevalance of prostatitis like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001; 165:842-5.
  • Murphy A B, Macejko A, Taylor A, Nadler R B. Chronic prostatitis: management strategies. Drugs. 2009; 69:71-84.
  • Collins MM, Stafford RS, O’leary MP. How common is prostatitis? a national survey of physician visits. J Urol. 1998; 159:1224-28.
  • Roberts RO, Jacobson DJ, Girman CJ. Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol. 2002;168:2467-71.
  • Pontari MA. Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment. Drugs Aging. 2003; 20:1111-25.
  • Ku JH, Kim SW, Paick JS. Epidemiologic risk factors for chronic prostatitis. Int J Androl. 2005; 28:317-27.
  • Krieger JN, Lee SW, Jeon J. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008; 31 (Suppl.1):85-90.
  • Wallner LP, Clemens JQ, Sarma AV. Prevalence of and risk factors for prostatitis in African American men: the Flint Men’s Health Study. Prostate. 2009; 69:24-32.
  • Murphy AB, Nadler RB. Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management. Expert OpinPharmacother. 2010; 11:1255-61.
  • Lipsky BA, Byren L, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis. 2010; 50:1641-52.

Prostatit Tedavisinde Güncel Yaklaşımlar

Year 2013, Volume: 22 Issue: 1, 130 - 141, 01.03.2013

Abstract

Prostat bezinin enfeksiyonu veya inflamasyonu olarak bilinen prostatit farklı klinik tablolarda görülebilmektedir. Genellikle orta yaş ve genç erişkin erkekleri etkileyen ağrılı ve yaşam kalitesini bozucu bir durumdur.Son yıllarda yeni bir sınıflandırma sisteminin ortaya atılmasıyla hastalığın değerlendirilmesi, sınıflandırılması ve tedavisinde daha bilinçli bir yaklaşımın ortaya çıkması mümkün olmuştur. Bununla birlikte literatürde kesin etkili tedavi yöntemi henüz tanımlanmamıştır.

References

  • Benoit G, Gillpt C, Jardın A. Reflection etpropositionsur la nomenclature de la prostate. Surg Radiol Anat. 1992; 15:325-32.
  • Pfau A. Prostatistis: a continuing enigma. UrolClin North Am. 1986;13:695-715.
  • Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and uretritis. Invest Urol. 1968; 5:492-518.
  • Nickel JC, Downey J, Hunter D, Clark J. Prevalance of prostatitis like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001; 165:842-5.
  • Murphy A B, Macejko A, Taylor A, Nadler R B. Chronic prostatitis: management strategies. Drugs. 2009; 69:71-84.
  • Collins MM, Stafford RS, O’leary MP. How common is prostatitis? a national survey of physician visits. J Urol. 1998; 159:1224-28.
  • Roberts RO, Jacobson DJ, Girman CJ. Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol. 2002;168:2467-71.
  • Pontari MA. Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment. Drugs Aging. 2003; 20:1111-25.
  • Ku JH, Kim SW, Paick JS. Epidemiologic risk factors for chronic prostatitis. Int J Androl. 2005; 28:317-27.
  • Krieger JN, Lee SW, Jeon J. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008; 31 (Suppl.1):85-90.
  • Wallner LP, Clemens JQ, Sarma AV. Prevalence of and risk factors for prostatitis in African American men: the Flint Men’s Health Study. Prostate. 2009; 69:24-32.
  • Murphy AB, Nadler RB. Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management. Expert OpinPharmacother. 2010; 11:1255-61.
  • Lipsky BA, Byren L, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis. 2010; 50:1641-52.
There are 13 citations in total.

Details

Primary Language Turkish
Journal Section Review
Authors

Volkan İzol This is me

Bahtiyar Hüseynov This is me

İbrahim Atilla Arıdoğan This is me

Publication Date March 1, 2013
Published in Issue Year 2013 Volume: 22 Issue: 1

Cite

AMA İzol V, Hüseynov B, Arıdoğan İA. Prostatit Tedavisinde Güncel Yaklaşımlar. aktd. March 2013;22(1):130-141.